Improved reliability of the primary plate bacitracin test on throat cultures with sulfamethoxazole-trimethoprim blood agar plates.
AUTOR(ES)
Kurzynski, T
RESUMO
The primary plate bacitracin differentiation disk susceptibility test identified 85% of group A streptococci from throat cultures on SXT-BA(CO2) plates within 24 h, as compared to only 26% on a conventional sheep blood agar plate.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=272972Documentos Relacionados
- Evaluation of Sulfamethoxazole- Trimethoprim Blood Agar Plates for Recovery of Group A Streptococci from Throat Cultures
- Prediction of sulfamethoxazole-trimethoprim synergistic action against members of the family Enterobacteriaceae with a two-plate agar dilution breakpoint MIC system.
- Sulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae.
- Spurious sulfamethoxazole-trimethoprim resistance of Salmonella typhi.
- Minimum Bactericidal Concentration of Sulfamethoxazole-Trimethoprim for Haemophilus influenzae: Correlation with Prophylaxis
